Compound Profiles
IGF-1 DES
Truncated IGF-1 Analog | Localized Muscle Growth
IGF-1 DES activates the IGF-1 receptor (IGF-1R) and downstream PI3K/Akt/mTOR and MAPK/ERK signaling pathways, driving both muscle hypertrophy and hyperplasia. Because it lacks the tripeptide Gly-Pro-Glu at the N-terminus, it cannot bind to IGFBPs that normally sequester ~98% of circulating IGF-1.
IGF-1 LR3
Modified Growth Factor Analog | Muscle Growth
Functions as a full IGF-1 receptor agonist activating PI3K/Akt/mTOR and MAPK/ERK pathways. The modifications prevent protein sequestration, maintaining elevated free circulating levels for extended anabolic effects.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take IGF-1 DES with IGF-1 LR3?
Yes, but with caution. Do not stack with IGF-1 DES. Both are IGF-1 analogs acting on the same receptor. Choose one or the other based on whether you want systemic (LR3) or localized (DES) effects. Regular monitoring is advised.
Is IGF-1 DES and IGF-1 LR3 safe together?
Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting. Monitor accordingly.
What are the interactions between IGF-1 DES and IGF-1 LR3?
Do not stack with IGF-1 DES. Both are IGF-1 analogs acting on the same receptor. Choose one or the other based on whether you want systemic (LR3) or localized (DES) effects. This assessment has 90% confidence and is based on documented research data.
How should I time IGF-1 DES and IGF-1 LR3?
IGF-1 DES has a half-life of 20-30 minutes and IGF-1 LR3 has a half-life of 20-30 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.